한국Boehringer Ingelheim announced on the 24th that it has appointed Anamaria Boi as the new President and Head of Human Pharmaceuticals, effective from the 15th.


Anamaria Boi, New President of Boehringer Ingelheim Korea<br>[Photo by Boehringer Ingelheim Korea]

Anamaria Boi, New President of Boehringer Ingelheim Korea
[Photo by Boehringer Ingelheim Korea]

View original image

President Boi has accumulated 24 years of experience in the pharmaceutical industry, covering various fields such as management, marketing, sales, and ESG (Environmental, Social, and Governance). She joined Boehringer Ingelheim in 2009 as a Marketing Manager at the Romania branch. Since then, she has served as National Sales Manager in Romania, Regional Marketing Manager for the Respiratory Business Unit at the Austria branch, President of Romania, and Sales and Commercial Director of Human Pharmaceuticals at the Russia branch.


President Boi is recognized for significantly contributing not only to sales performance but also to applying Boehringer Ingelheim’s core corporate values to organizational culture. In 2020, she participated in developing the 'Sustainable Development for Generations (SD4G)' framework, Boehringer Ingelheim’s global core strategy for a sustainable society. After being appointed as Emerging Markets Regional Business Manager at the headquarters in Bonn, Germany in 2021, she has led business strategy development and execution across markets including Mexico, Brazil, South America, India, the Middle East, Africa, and Turkey, while spearheading strategies to improve treatment accessibility for underserved populations.



President Boi said, "I am deeply honored to join the journey of contributing to improving the quality of life for people and animals through innovative therapies in Korea, one of Boehringer Ingelheim’s key markets." She added, "I look forward to growing together with the employees of Boehringer Ingelheim Korea, who regard trust, respect, and passion not just as words but as core values to fulfill our mission, based on the new corporate claim 'Life Forward.'"


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing